Practice update for flu vaccines and egg allergies (VIDEO)

In a time when vaccine hesitancy is contributing to a rise in measles cases, an understanding of why parents are hesitant is key to help change their narrative.

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

The new data, published in The Lancet, showed that nirsevimab substantially reduced RSV hospitalizations.

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

New cohort analyses observe a statistically raised risk of myocarditis, pericarditis and seizures among certain age groups, though the data do not go against FDA recommendations.

Cohort analysis shows the rate of RSV hospitalizations among children up to 5 years old skyrocketed in 2021—and then nearly doubled again in 2022—compared to pre-pandemic rates.